Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 81,506 | 77,274 | 78,472 | 71,642 | 66,966 |
| Cost of Goods | 17,071 | 16,853 | 18,045 | 10,140 | 6,942 |
| Gross Profit | 64,435 | 60,421 | 60,427 | 61,502 | 60,024 |
| Operating Expenses | 46,555 | 48,664 | 53,110 | 46,784 | 42,510 |
| Operating Income | 17,951 | 12,610 | 7,362 | 14,858 | 18,456 |
| Interest Expense | 11,672 | 11,219 | 10,902 | 10,591 | 10,042 |
| Other Income | -314 | -247 | -85 | -192 | -130 |
| Pre-tax Income | 5,965 | 1,144 | -3,625 | 4,075 | 8,284 |
| Income Tax | 693 | 524 | 1,826 | 361 | 1,133 |
| Net Income Continuous | 5,272 | 620 | -5,451 | 3,714 | 7,151 |
| Minority Interests | N/A | N/A | N/A | 3 | 34 |
| Net Income | $5,272 | $620 | $-5,451 | $3,711 | $7,117 |
| EPS Basic Total Ops | 0.28 | 0.04 | -0.28 | 0.19 | 0.36 |
| EPS Basic Continuous Ops | 0.28 | 0.04 | -0.28 | 0.19 | 0.36 |
| EPS Diluted Total Ops | 0.27 | 0.04 | -0.28 | 0.19 | 0.36 |
| EPS Diluted Continuous Ops | 0.27 | 0.04 | -0.28 | 0.19 | 0.36 |
| EBITDA(a) | $47,425 | $41,729 | $38,389 | $40,423 | $42,399 |